IDiyas

For the Inventor, By the Inventor

Sandwich, United Kingdom

Geoffrey E Gymer

USPTO Granted Patents = 14

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 141(Granted Patents)


Location History:

  • Sandwich, EN (1977)
  • Canterbury, GB (1984 - 1991)
  • County of Kent, GB (2003)
  • Sandwich, GB (1978 - 2006)

Company Filing History:

goldMedal13 out of 4,455 
 
Pfizer Corporation
 patents
silverMedal1 out of 1 
 
Pfeizer Inc.
 patent

Years Active: 1977-2006

Loading Chart...
14 patents (USPTO):Explore Patents
1. 7129234 - Phenyl heterocyclyl ethers (2006-10-31),
2. 6979690 - Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators (2005-12-27),
3. 6624162 - Imidazopyridine compounds as 5-HT4 receptor modulators (2003-09-23),
4. 6610747 - Phenoxybenzylamine derivatives as SSRIs (2003-08-26),
5. 5047548 - 3-aryl-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butyramide and derivatives as (1991-09-10),
6. 5023258 - Triazole antifungal agents (1991-06-11),
7. 4960782 - Triazole antifungal agents (1990-10-02),
8. 4661507 - Antifungal S-ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) (1987-04-28),
9. 4585778 - Triazole antifungal agents (1986-04-29),
10. 4507484 - Triazole antifungal agents (1985-03-26),
11. 4483863 - Triazole antifungal agents (1984-11-20),
12. 4435399 - 2-Aryl-1-(imidazol-1-yl)-8-(4-piperazin-1-ylphenoxy) octan-2-ol (1984-03-06),
13. 4107314 - Antifungal thio-alkyl-imidazole derivatives (1978-08-15),
14. 4062966 - 1-Aryl-2-(1-imidazolyl) alkyl ethers and thioethers (1977-12-13),

Title: The Innovative Journey of Geoffrey E. Gymer

Introduction: Geoffrey E. Gymer, a notable inventor based in Sandwich, GB, has made significant contributions to the field of pharmaceutical inventions. With a portfolio of 14 patents, Gymer has dedicated his career to developing novel compounds aimed at enhancing human health. His work predominantly focuses on providing innovative solutions for various gastrointestinal disorders.

Latest Patents: Among Geoffrey E. Gymer's most recent innovations are two noteworthy patents. The first pertains to phenyl heterocyclyl ethers, which involves unique compounds showing potential therapeutic benefits. The second patent revolves around oxo or oxy-pyridine compounds that act as 5-HT4 receptor modulators. These compounds are especially important for the treatment of conditions such as gastroesophageal reflux disease, non-ulcer dyspepsia, and irritable bowel syndrome. Notably, these inventions contribute to the development of pharmaceutical compositions that incorporate these groundbreaking compounds, thereby improving patient outcomes.

Career Highlights: Geoffrey E. Gymer's career includes valuable experiences at prominent companies such as Pfizer Corporation and Pfizer Inc. His time at these renowned organizations has provided him with a solid foundation in pharmaceutical research and innovation, allowing him to push the boundaries of science and develop effective therapeutic solutions.

Collaborations: Throughout his career, Gymer has had the privilege of collaborating with influential professionals in the field, including Kenneth Richardson and Alan Stobie. These partnerships have facilitated the exchange of ideas and fostered an environment of creativity and innovation, which is vital for the advancement of pharmaceutical research.

Conclusion: Geoffrey E. Gymer stands out as a pioneering figure in the realm of pharmaceutical inventions. His 14 patents reflect his dedication to enhancing the effectiveness of treatments for gastrointestinal disorders. As he continues to innovate and collaborate with esteemed colleagues, Gymer’s contributions will undoubtedly have a lasting impact on the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…